Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,023
Closed -$545K 1300
2022
Q4
$545K Buy
+5,023
New +$444K ﹤0.01% 815
2020
Q4
Sell
-1,018
Closed -$43K 1443
2020
Q3
$43K Buy
1,018
+22
+2% +$851 ﹤0.01% 1370
2020
Q2
$36K Buy
996
+336
+51% +$8.89K ﹤0.01% 1396
2020
Q1
$27K Hold
660
﹤0.01% 1928
2019
Q4
$27K Buy
660
+138
+26% +$4.82K ﹤0.01% 1928
2019
Q3
$14 Buy
522
+53
+11% +$1.28K ﹤0.01% 2209
2019
Q2
$9 Hold
469
﹤0.01% 2410
2019
Q1
$12 Sell
469
-32
-6% -$876 ﹤0.01% 2288
2018
Q4
$13 Buy
+501
New +$11.7K ﹤0.01% 2163
2017
Q3
Sell
-235
Closed -$1K 2751
2017
Q2
$1K Hold
235
﹤0.01% 2581
2017
Q1
$1K Buy
+235
New +$1.63K ﹤0.01% 2581
2016
Q2
Sell
-491
Closed -$3K 2564
2016
Q1
$3K Buy
491
+127
+35% +$1.18K ﹤0.01% 2310
2015
Q4
$2K Hold
364
﹤0.01% 2448
2015
Q3
$4K Buy
364
+116
+47% +$1.68K ﹤0.01% 2348
2015
Q2
$3K Buy
+248
New +$3.51K ﹤0.01% 2335
2013
Q3
Sell
-21,018
Closed -$346K 2218
2013
Q2
$346K Buy
+21,018
New +$341K ﹤0.01% 897

Other funds holding CROX

Glenmede Trust's CROX Position: Q1 2023 in Review

Glenmede Trust sold out of Crocs (CROX) in Q1 2023, closing a stake of 5,023 shares — an estimated $545K sold.

Glenmede Trust first reported a position in CROX in Q2 2013 and held it in 16 quarters. The position peaked at $545K in Q4 2022. 436 funds tracked by Wall St. Rank hold CROX as of Q1 2023.

  • Glenmede Trust reported no remaining Crocs position as of Q1 2023 after selling out during the quarter.
  • Glenmede Trust sold 5,023 Crocs shares in Q1 2023, an estimated $545K.
  • Glenmede Trust first reported a position in Crocs in Q2 2013 and held it in 16 quarters.
  • Glenmede Trust's Crocs position peaked at $545K in Q4 2022.
  • 436 funds tracked by Wall St. Rank held Crocs as of Q1 2023.

Based on Glenmede Trust's 13F filing for Q1 2023, filed 15 May 2023.